Search Form
First, enter a politician or zip code
Now, choose a category

Public Statements

Public Statements

Date Title Officials Location
Nov. 28, 2017 McCaskill Continues Fight to Restore DEA Enforcement Power During Opioid Epidemic at Senate Roundtable Sen. Claire McCaskill Washington, DC
Nov. 22, 2017 McCaskill Seeks Details on Preventing Fentanyl and Illicit Opioid Shipments to the U.S. Sen. Claire McCaskill Washington, DC
Nov. 20, 2017 Letter to the Hon. Megan Brennan, Postmaster General - McCaskill Seeks Details on Preventing Fentanyl and Illicit Opioid Shipments to the U.S. Sen. Claire McCaskill Washington, DC
Nov. 20, 2017 Letter to the Hon. Rex Tillerson, Secretary of State - McCaskill Seeks Details on Preventing Fentanyl and Illicit Opioid Shipments to the U.S. Sen. Claire McCaskill Washington, DC
Nov. 16, 2017 McCaskill Pushes Bipartisan Fix to Better Fund Opioid Treatment Sen. Claire McCaskill Washington, DC
Nov. 16, 2017 Letter to Robert W. Patterson, Acting Administrator, DEA, - Allow Chief Administrative Law Judge to Testify at Opioid Enforcement Roundtable Sen. Claire McCaskill Washington, DC
Nov. 15, 2017 Momentum Builds for McCaskill's Bill to Repeal Law Curbing DEA Opioid Enforcement Sen. Claire McCaskill Washington, DC
Nov. 6, 2017 Letter to Kevin K. McAleenan, Acting Commissioner of US Customs and Border Protection - Target Opioid Smuggling Sen. Claire McCaskill Washington, DC
Nov. 1, 2017 McCaskill Statement on Final Report from President Trump's Commission on Combating Drug Addiction and the Opioid Crisis Sen. Claire McCaskill Washington, DC
Nov. 1, 2017 McCaskill Statement on Final Report from President Trump's Commission on Combating Drug Addiction and the Opioid Crisis Sen. Claire McCaskill Washington, DC
Oct. 26, 2017 Stone County Approves Prescription Drug Monitoring Program--McCaskill Statement Sen. Claire McCaskill Washington, DC
Oct. 26, 2017 McCaskill Issues Statement Following Arrest of Former Insys Therapeutics CEO John Kapoor Sen. Claire McCaskill Washington, DC
Oct. 26, 2017 McCaskill Statement on President Trump's Declaration of the Opioid Crisis as a Public Health Emergency Sen. Claire McCaskill Washington, DC
Oct. 26, 2017 McCaskill Statement on President Trump's Declaration of the Opioid Crisis as a Public Health Emergency Sen. Claire McCaskill Washington, DC
Oct. 26, 2017 McCaskill Issues Statement Following Arrest of Former Insys Therapeutics CEO John Kapoor Sen. Claire McCaskill Washington, DC
Oct. 18, 2017 Letter to the Hon. John Boozman, Chairman of the Senate Appropriations Committee, the Hon. Jon Tester, Ranking Member - More Border Security Funds at Ports of Entry Sen. Claire McCaskill Washington, DC
Oct. 17, 2017 McCaskill Statement on Withdrawal of Rep. Tom Marino as Director of Office of National Drug Control Policy Sen. Claire McCaskill Washington, DC
Oct. 16, 2017 McCaskill Announces Legislation Repealing 2016 Law After Reports that It Prevented Aggressive DEA Enforcement of Opioid Distributors Sen. Claire McCaskill Washington, DC
Sept. 20, 2017 McCaskill Statement on Joplin, Jasper County Prescription Drug Monitoring Programs Approval Sen. Claire McCaskill Washington, DC
Sept. 15, 2017 Blunt Announces $3.9 Million Grant to Expand Access to Programs for Mental Health, Opioid Use Disorder Treatment Sen. Roy Blunt Washington, DC
Sept. 12, 2017 McCaskill Continues Investigation Into Opioid Crisis with Committee Roundtable on Opioids Sales and Marketing Sen. Claire McCaskill Washington, DC
Sept. 6, 2017 McCaskill Opioid Investigation Releases First Report Detailing Systemic Manipulation of Prior Authorization Process by Insys Therapeutics Sen. Claire McCaskill Washington, DC
Aug. 7, 2017 Naloxone Access, Affordability Is Focus of McCaskill Inquiry Sen. Claire McCaskill Washington, DC
Aug. 2, 2017 Letter to Seamus Mulligan, CEO of Adapt Pharmaceuticals, Jack Y. Zhang, CEO of Amphastar Pharmaceuticals, Spencer Williamson, CEO of Kaleo Pharma, and Ian C. Read, CEO of Pfizer - Price of Naloxone Sen. Claire McCaskill Washington, DC
July 27, 2017 BREAKING: McCaskill Opioid Investigation Expands to Include Distributors and Additional Manufacturers Sen. Claire McCaskill Washington, DC
July 26, 2017 McCaskill's Bipartisan Bill to Combat Drug and Weapons Trafficking Unanimously Passes Key Committee Sen. Claire McCaskill Washington, DC
July 25, 2017 Springfield, Greene County Approve Prescription Drug Monitoring Programs--McCaskill Statement Sen. Claire McCaskill Washington, DC
July 17, 2017 McCaskill on Governor's Prescription Drug Monitoring Announcement Sen. Claire McCaskill Washington, DC
July 17, 2017 Hartzler Expresses Support for Missouri Prescription Drug Monitoring Program Rep. Vicky Hartzler Washington, DC
July 14, 2017 Stopping Illegal Opioids from Entering the U.S. Is Focus of McCaskill-Backed Bipartisan Bill Sen. Claire McCaskill Washington, DC
July 11, 2017 Letter to the Hon. Chuck Rosenberg, Acting Administrator of the United States Drug Enforcement Administration - Senators Urge DEA to Lower Opioid Quotas to Combat Prescription Drug Abuse Sen. Claire McCaskill Washington, DC
June 28, 2017 Food and Drug Administration Announces Action Plan that Mirrors Collins, McCaskill, Cotton, Franken Bipartisan Bill to Lower Cost of Prescription Drugs Sen. Claire McCaskill Washington, DC
June 13, 2017 Highlighting Bipartisan Plan to Lower Cost of Prescription Drugs, McCaskill, Collins Praise Food and Drug Administration Chief's Remarks Sen. Claire McCaskill Washington, DC
June 2, 2017 Following McCaskill Request, Department of Justice Inspector General to Investigate Opioid Enforcement Sen. Claire McCaskill Washington, DC
May 31, 2017 McCaskill Targets Opioid Shipments from China During Senate Hearing Sen. Claire McCaskill Washington, DC
May 31, 2017 McCaskill Targets Opioid Shipments from China During Senate Hearing Sen. Claire McCaskill Washington, DC
May 23, 2017 After Pressure from McCaskill, Administration Backs Off Proposal to Eliminate Office of National Drug Control Policy Sen. Claire McCaskill Washington, DC
May 19, 2017 Given Impact on Missouri if National Drug Effort Eliminated, McCaskill Urges Administration to Fund Program Sen. Claire McCaskill Washington, DC
May 17, 2017 McCaskill to Greitens: Special Session Needed to Combat Missouri's Opioid Epidemic Sen. Claire McCaskill Washington, DC
May 16, 2017 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding Rep. William Clay Washington, DC
May 13, 2017 McCaskill: "Bitterly disappointed' Jefferson City Fails Once Again on Prescription Drug Monitoring Program Sen. Claire McCaskill Washington, DC
May 12, 2017 McCaskill to Trump: "I'm committed to working with you' to Curb Opioid Epidemic Sen. Claire McCaskill Washington, DC
May 11, 2017 McCaskill, Collins Effort to Tackle Cost of Rx Drugs Clears Key Committee Hurdle Sen. Claire McCaskill Washington, DC
May 9, 2017 McCaskill, Johnson Ask DEA for Information Regarding Drug Diversion Sen. Claire McCaskill Washington, DC
May 8, 2017 Creating Generic Competition for Prescription Drugs is Aim of McCaskill-backed Bipartisan Effort Sen. Claire McCaskill Washington, DC
May 8, 2017 Letter to Charles Rosenberg, Acting Administrator of the Drug Enforcement Administration - Information Regarding Drug Diversion Sen. Claire McCaskill Washington, DC
May 4, 2017 Blunt Votes to Fund Key Missouri Priorities Sen. Roy Blunt Washington, DC
April 19, 2017 Blunt Announces $10 Million Grant to Combat Opioid Epidemic in Missouri Sen. Roy Blunt Washington, DC
April 11, 2017 Continuing Support for Prescription Drug Monitoring Program, McCaskill Advocates for County-Level Funding Sen. Claire McCaskill Washington, DC
April 5, 2017 Missouri Senate Must Pass Prescription Drug Monitoring Bill, McCaskill Urges Sen. Claire McCaskill Washington, DC
April 4, 2017 Letter to the Hon. Donald Trump, President of the United States - Lower Prescription Drug Prices Rep. Emanuel Cleaver Washington, DC
March 29, 2017 McCaskill Statement on Chris Christie Leading White House Addiction Commission Sen. Claire McCaskill Washington, DC
March 28, 2017 Opioid Manufacturers are Subject of New McCaskill-Led, Wide-Ranging Investigation Sen. Claire McCaskill Washington, DC
March 6, 2017 Letter to Michael Horowitz, Inspector General - Requesting Investigation into Opioid Distributor Enforcement Sen. Claire McCaskill Washington, DC
Feb. 21, 2017 Letter to the Hon. Spencer Williamson, President and CEO of Kaleo Pharmaceuticals - Demanding Answers to Recent Naloxone Price Spike Rep. Emanuel Cleaver Washington, DC
Feb. 6, 2017 Continuing Work to Combat Opioid Epidemic, McCaskill Meets With Missouri Prosecutors Sen. Claire McCaskill Washington, DC
Jan. 26, 2017 Prescription Drug Monitoring Funds Now Available to Missouri Counties & Cities Following McCaskill Efforts Sen. Claire McCaskill Washington, DC
Jan. 23, 2017 Columbia Moves to Establish City Prescription Drug Monitoring Program--McCaskill Statement Sen. Claire McCaskill Washington, DC
Jan. 11, 2017 BREAKING: Missouri Counties Can Now Get Funding for Local Prescription Drug Monitoring Programs Thanks to McCaskill Efforts Sen. Claire McCaskill Unknown
Dec. 7, 2016 Blunt Votes to Speed Progress Toward Life-Saving Cures Sen. Roy Blunt Washington, DC
Nov. 30, 2016 Long Comments on the Passage of the Final 21st Century Cures bill Rep. Billy Long Washington, DC
Nov. 15, 2016 Gold Star Families Voices Act Sen. Roy Blunt Washington, DC
Sept. 20, 2016 McCaskill Announces Resource and Information Page During Prescription Opioid and Heroin Epidemic Awareness Week Sen. Claire McCaskill Washington, DC
Sept. 14, 2016 Bipartisan Group of Senators Respond to Report Showing that 20% of Medicare Generic Drugs Have More Than Doubled in Price Sen. Claire McCaskill Washington, DC
Sept. 6, 2016 $5 Million Opioid Treatment, Prevention Grant is Great News for Missouri -- McCaskill Sen. Claire McCaskill St. Louis, MO
Aug. 8, 2016 McCaskill Seeks Answers on Administration Efforts to Monitor Opioid Prescribers Sen. Claire McCaskill Washington, DC
Aug. 4, 2016 Letter to Chuck Rosenberg, Acting Administrator of the Drug Enforcement Administration - Request Update on DEA Efforts to Monitor Controlled Substances Prescribers Sen. Claire McCaskill Washington, DC
Aug. 2, 2016 Letter to The Honorable Andy Slavitt, Acting Administrator, Centers for Medicare & Medicaid Services - Urging CMS to Expand Substance Abuse Treatment Coverage Sen. Claire McCaskill Washington, DC
July 22, 2016 In Columbia, Solutions to Combat Nation's Opioid Epidemic are Focus of McCaskill-Vilsack Town Hall Sen. Claire McCaskill Columbia, MO
July 14, 2016 Letter to Mitch McConnell, Majority Leader of the United States Senate - As Congress Clears Comprehensive Addiction and Recovery Bill, Reed Calls for Emergency Funding for Opioid Epidemic Sen. Claire McCaskill Washington, DC
July 13, 2016 Blunt Touts Passage of Bill to Combat Opioid Epidemic Sen. Roy Blunt Washington, DC
July 13, 2016 McCaskill Delivers for Missouri on Federal Legislation Combatting Opioid Epidemic Sen. Claire McCaskill Washington, DC
July 13, 2016 Letter to The Honorable Mitch McConnell. Majority Leader, United States Senate - Commit to Passing Real, Immediate Funding to Fight Opioid and Heroin Epidemic and Actually Carry Out Programs Authorized in CARA Bill Sen. Claire McCaskill Washington, DC
July 8, 2016 Hartzler Supports Legislation to Address Widespread Opioid Abuse Rep. Vicky Hartzler Washington, DC
June 21, 2016 Bipartisan Senators Comment on Deficiencies in Monitoring Eligibility of Controlled Substance Prescribers Sen. Claire McCaskill Washington, DC
June 14, 2016 Letter to the Honorable Sylvia Mathews Burwell, Secretary of the US Department of Health and Human Services - Call for Affordable Medical Treatment for Opioid Dependency Rep. Ann Wagner Washington, DC
June 9, 2016 Blunt Secures Missouri Priorities in Committee-Passed Labor, Health and Human Services, and Education Bill Sen. Roy Blunt Washington, DC
June 7, 2016 Efforts to Combat Opioid Epidemic Get Boost in Blunt-Led Appropriations Bill Sen. Roy Blunt Washington, DC
June 7, 2016 McCaskill Seeks Drug Pricing Information on Opioid Overdose Reversal Drugs Sen. Claire McCaskill Washington, DC
June 6, 2016 Chairman Collins, Ranking Member McCaskill Seek Information from Companies on Efforts to Preserve Accessibility of Opioid Overdose Reversal Drug Sen. Claire McCaskill Washington, DC
May 13, 2016 Blaine's Bulletin: Combating the Opioid Epidemic Rep. Blaine Luetkemeyer Washington, DC
May 13, 2016 KOLR (CBS Springfield) - Prescription Drug Monitoring Bill Dies In Missouri Legislature Sen. Claire McCaskill Unknown
May 13, 2016 Congressman Cleaver Votes for Legislation to Address the Opioid Epidemic Rep. Emanuel Cleaver Washington, DC
May 11, 2016 Nurturing and Supporting Healthy Babies Act Rep. Ann Wagner Washington, DC
May 11, 2016 Hartzler: Opioid epidemic "affects us all' Rep. Vicky Hartzler Washington, DC
April 27, 2016 Hearing of the Senate Aging Committee - Sen. McCaskill's Opening Statement on "Valeant Pharmaceuticals' Business Model: the Repercussions for Patients and the Health Care System" Sen. Claire McCaskill Washington, DC
April 26, 2016 Letter to Dr. Robert M. Califf, Commissioner of the Food and Drug Administration (FDA) - Sen. Cruz, Others Hammer FDA on Relaxed Standards for Abortion Drug Sen. Roy Blunt Washington, DC
April 26, 2016 Letter to Dr. Robert M. Califf, Commissioner of the Food and Drug Administration (FDA) - Sen. Cruz, Others Hammer FDA on Relaxed Standards for Abortion Drug Rep. Ann Wagner Washington, DC
April 26, 2016 Letter to Dr. Robert M. Califf, Commissioner of the Food and Drug Administration (FDA) - Sen. Cruz, Others Hammer FDA on Relaxed Standards for Abortion Drug Rep. Vicky Hartzler Washington, DC
April 26, 2016 Letter to Dr. Robert M. Califf, Commissioner of the Food and Drug Administration (FDA) - Sen. Cruz, Others Hammer FDA on Relaxed Standards for Abortion Drug Rep. Blaine Luetkemeyer Washington, DC
April 13, 2016 McCaskill Drills Down on Wasteful Spending in Central, South American Counternarcotics Efforts Sen. Claire McCaskill Washington, DC
April 11, 2016 Senate Special Committee on Aging Calls Business Meeting to Initiate Contempt Proceedings Against Valeant CEO Michael Pearson Sen. Claire McCaskill Washington, DC
March 9, 2016 Comprehensive Addiction and Recovery Bill Sen. Roy Blunt Washington, DC
Feb. 10, 2016 Hearing of the Senate Aging Committee - Opening Statement of Sen. McCaskill, Hearing on "Do You Know What Is in Your Suitcase? How Drug Traffickers Are Deceiving Seniors to Smuggle Contraband." Sen. Claire McCaskill Washington, DC
Feb. 10, 2016 McCaskill Brings to Light International Drug Smuggling Scam Involving Seniors Sen. Claire McCaskill Washington, DC
Feb. 8, 2016 Following Jefferson City Hearing, McCaskill Offers Advice on Opioid Epidemic to Key Official Sen. Claire McCaskill Washington, DC
Jan. 20, 2016 Democrat Missourian - Congresswoman Hartzler Visits Area Schools to Discuss Anti-drug Initiatives Rep. Vicky Hartzler Unknown
Jan. 19, 2016 McCaskill: Prescription Drug & Heroin Abuse Epidemic a "major public health crisis that affects every community across this nation' Sen. Claire McCaskill Washington, DC
Jan. 12, 2016 Health Care Research, Mental Health, and Prescription Drug Abuse Sen. Roy Blunt Washington, DC
Dec. 16, 2015 Omnibus Appropriations Bill Sen. Roy Blunt Washington, DC
Skip to top

Help us stay free for all your Fellow Americans

Just $5 from everyone reading this would do it.

Back to top